High
86.190
Open
82.505
VWAP
83.94
Vol
7.77M
Mkt Cap
9.90B
Low
81.780
Amount
651.76M
EV/EBITDA(TTM)
95.52
Total Shares
117.53M
EV
13.77B
EV/OCF(TTM)
11.98
P/S(TTM)
1.82
Albemarle Corporation is engaged in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. The Company’s segments include Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. Its Specialties business optimizes its portfolio of bromine and highly specialized lithium solutions. Its Specialties business serves a variety of industries, including energy, mobility, connectivity, and health. Specialty products are essential in both internal combustion and electric vehicles, from high-voltage cables and powertrains to airbags and tires. Its Ketjen segment includes clean fuels technologies (CFT), fluidized catalytic cracking (FCC) catalysts and additives, and performance catalyst solutions (PCS). It serves various markets such as grid storage, automotive, aerospace, conventional energy, and others.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
1.23B
-13.76%
-0.788
-2069.2%
1.28B
-5.23%
-0.541
-65.08%
1.29B
+5%
-0.500
-54.17%
Estimates Revision
The market is revising Downward the revenue expectations for Albemarle Corporation (ALB) for FY2025, with the revenue forecasts being adjusted by -1.98% over the past three months. During the same period, the stock price has changed by 44.71%.
Revenue Estimates for FY2025
Revise Downward

-1.98%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward

+6.1%
In Past 3 Month
Stock Price
Go Up

+44.71%
In Past 3 Month
19 Analyst Rating

-16.12% Downside
Wall Street analysts forecast ALB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALB is 70.61 USD with a low forecast of 29.00 USD and a high forecast of 107.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
10 Hold
3 Sell
Hold

-16.12% Downside
Current: 84.180

Low
29.00
Averages
70.61
High
107.00

-16.12% Downside
Current: 84.180

Low
29.00
Averages
70.61
High
107.00
Mizuho
John Roberts
Neutral
maintain
$65 -> $76
2025-07-15
Reason
Mizuho
John Roberts
Price Target
$65 -> $76
2025-07-15
maintain
Neutral
Reason
Mizuho analyst John Roberts raised the firm's price target on Albemarle to $76 from $65 and keeps a Neutral rating on the shares. The firm updated price targets in chemicals and packaging ahead of the Q2 reports. It says the new targets reflect the recent market multiple recovery. Mizuho's top picks are all specialty and defensive names: Corteva (CTVA), Crown (CCK) and Linde (LIN). A pause in tariffs likely pulled forward some demand, which could create a year-end slowdown, the analyst tells investors in a research note.
UBS
Neutral -> Sell
downgrade
$64 -> $57
2025-07-11
Reason
UBS
Price Target
$64 -> $57
2025-07-11
downgrade
Neutral -> Sell
Reason
UBS downgraded Albemarle to Sell from Neutral with a price target of $57, down from $64. The firm believes lithium markets will remain oversupplied through 2026. While Albemarle realized pricing moved up modestly year-over-year, UBS's 2026 lithium price forecast is 6%-15% below consensus, the analyst tells investors in a research note. The firm believes 2026 consensus EBITDA expectations for Albemarle are 14% too high.
Piper Sandler
Charles Neivert
Underweight
downgrade
$85 -> $68
2025-05-14
Reason
Piper Sandler
Charles Neivert
Price Target
$85 -> $68
2025-05-14
downgrade
Underweight
Reason
Piper Sandler analyst Charles Neivert lowered the firm's price target on Albemarle to $68 from $85 and keeps an Underweight rating on the shares.
Berenberg
Andres Castanos-Mollor
Hold
downgrade
$92 -> $74
2025-05-13
Reason
Berenberg
Andres Castanos-Mollor
Price Target
$92 -> $74
2025-05-13
downgrade
Hold
Reason
Berenberg analyst Andres Castanos-Mollor lowered the firm's price target on Albemarle to $74 from $92 and keeps a Hold rating on the shares. The company reported strong Q1 results on April 27 but the print has not improved short-term expectations nor had a lasting impact on the share price, the analyst tells investors in a research note. The firm believes e Albemarle shares will remain an underperformer until lithium prices recover.
Citigroup
Patrick Cunningham
Hold
Maintains
$85 → $64
2025-04-15
Reason
Citigroup
Patrick Cunningham
Price Target
$85 → $64
2025-04-15
Maintains
Hold
Reason
Citi analyst Patrick Cunningham lowered the firm's price target on Albemarle to $64 from $85 and keeps a Neutral rating on the shares. The firm reduced lithium estimates and target multiples ahead of Q1 earnings. Citi sees tariffs disputes as a potential incremental headwind to global auto sales and says it is likely to keep prices depressed in the near term. Energy storage systems battery demand is also at risk with 20% of Chinese output exported to the U.S., the analyst tells investors in a research note.
Baird
Ben Kallo
Hold
Maintains
$77 → $60
2025-04-15
Reason
Baird
Ben Kallo
Price Target
$77 → $60
2025-04-15
Maintains
Hold
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Albemarle Corp (ALB.N) is -34.66, compared to its 5-year average forward P/E of 512.07. For a more detailed relative valuation and DCF analysis to assess Albemarle Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
512.07
Current PE
-34.66
Overvalued PE
2665.50
Undervalued PE
-1641.36
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair
5Y Average EV/EBITDA
15.57
Current EV/EBITDA
16.37
Overvalued EV/EBITDA
22.59
Undervalued EV/EBITDA
8.55
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
3.44
Current PS
1.99
Overvalued PS
5.22
Undervalued PS
1.67
Financials
Annual
Quarterly
FY2025Q1
YoY :
-20.86%
1.08B
Total Revenue
FY2025Q1
YoY :
-112.46%
17.81M
Operating Profit
FY2025Q1
YoY :
-90.85%
-14.99M
Net Income after Tax
FY2025Q1
YoY :
-100.00%
0.00
EPS - Diluted
FY2025Q1
YoY :
-175.36%
362.76M
Free Cash Flow
FY2025Q1
YoY :
+390.20%
14.51
Gross Profit Margin - %
FY2025Q1
YoY :
-85.71%
-2.74
FCF Margin - %
FY2025Q1
YoY :
+275.41%
4.58
Net Margin - %
FY2025Q1
N/A
ROIC
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 127.15% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
367.7K
USD
2
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
6.2K
Volume
2
6-9
Months
8.4K
Volume
2
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
4
88.0K
Volume
Months
6-9
3
136.5K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
32.5K
USD
1
3-6
Months
48.5K
USD
3
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
2
65.0K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areSelling! The selling amount has increased 127.15% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
367.7K
USD
2
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ALB News & Events
Events Timeline
2025-07-21 (ET)
2025-07-21
09:55:01
Early notable gainers among liquid option names on July 21st

2025-07-17 (ET)
2025-07-17
09:55:01
Early notable gainers among liquid option names on July 17th

2025-07-10 (ET)
2025-07-10
09:55:02
Early notable gainers among liquid option names on July 10th

Sign Up For More Events
Sign Up For More Events
News
8.5
16:18 PMCNBCStocks making the biggest moves midday: Tesla, IBM, Union Pacific, American Eagle Outfitters and more
4.5
15:00 PMNASDAQ.COMThursday's ETF Movers: REMX, JETS
8.0
07-23NASDAQ.COMDaily Dividend Report: FTI,WES,BDX,ALB,CI,HAS
Sign Up For More News
People Also Watch

SRPT
Sarepta Therapeutics Inc
12.880
USD
-3.30%

EBR
Centrais Eletricas Brasileiras SA - Eletrobras
7.010
USD
-0.57%

FHN
First Horizon Corp
22.220
USD
-1.51%

AFG
American Financial Group Inc
125.770
USD
-2.04%

ACI
Albertsons Companies Inc
20.540
USD
-1.25%

DTM
DT Midstream Inc
100.710
USD
+1.55%

TTEK
Tetra Tech Inc
38.270
USD
-0.17%

PCOR
Procore Technologies Inc
74.310
USD
-0.59%

BIRK
Birkenstock Holding PLC
51.870
USD
+1.59%

TFII
TFI International Inc
89.110
USD
-1.04%
FAQ

What is Albemarle Corp (ALB) stock price today?
The current price of ALB is 84.18 USD — it has increased 6.84 % in the last trading day.

What is Albemarle Corp (ALB)'s business?

What is the price predicton of ALB Stock?

What is Albemarle Corp (ALB)'s revenue for the last quarter?

What is Albemarle Corp (ALB)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Albemarle Corp (ALB)'s fundamentals?

How many employees does Albemarle Corp (ALB). have?
